Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai
Phase 2
Completed
- Conditions
- Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied
- Interventions
- Drug: kandhaga rasayanam
- Registration Number
- NCT02238912
- Lead Sponsor
- National institute of Siddha
- Brief Summary
this study is intended to find out the therapeutic efficacy of the siddha drug Kandhaga Rasayanam in Padarthamarai ( Ring worm infection )
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- patients clinically diagnosed with tinea infection.
- direct microscopy skin scraping test positive.
Exclusion Criteria
- pregnant or nursing women.
- use of other topical or oral antifungals, immunosuppressive drugs, anthelmintic drugs either currently or during 2 weeks preceeding initiation of drug trial.
- allergy or hyperensitivity to any component of the drug.
- clinical case of eczema, lichen planus, pityriasis versicolor, drug induced eruptions, urticaria, intertrigo, tinea ungium.
- diabetic patients.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Kandhaga Rasayanam- single arm kandhaga rasayanam Kandhaga Rasayanam- 2grams twice a day for 45 days
- Primary Outcome Measures
Name Time Method skin scrapping test 45 days
- Secondary Outcome Measures
Name Time Method itching, quality of life 45 days
Trial Locations
- Locations (1)
National institute of siddha
🇮🇳Chennai, Tamilnadu, India